Search clinical trials for: L-alanyl-L-glutamine dipeptide

Total 2575 results

Scandinavian Critical Care Trials Group

Terminated

Scandinavian Intensive Care Unit (ICU) Glutamine Study

ICU Patients

Sweden
National Cardiovascular Center Harapan Kita Hospital...

Completed

Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF

Coronary Artery Disease | Coronary Artery Bypass | Cardiopulmonary Bypass

Indonesia
Instituto Mexicano del Seguro Social

Completed

Effect of Parenteral Glutamine on Myocardial Injury and Inflammation Biomarkers

Insufficiency;Cardiac

Mexico
Centre Hospitalier Universitaire de Besancon

Unknown

Citrullinemia for the Prediction of Enteral Nutrition Tolerance Among Critically Ill Patients (PREDICT)

Biomarkers | Enteral Nutrition | Intensive Care Unit
Meshalkin Research Institute of Pathology of Circulation

Completed

Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass

Coronary Artery Disease

Russian Federation
University Hospital Muenster
Fresenius Kabi; IZKF (Interdisciplinary Centre for Clinical Research (IZKF)...

Completed

Reduction of Occurence of Acute Kidney Injury (AKI) Through Administration of Glutamine (Glacé)

Acute Kidney Injury | Cardiac Surgery

Germany
Yuejiang Liu

Completed

Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery

Coronary Heart Disease | Rheumatic Heart Disease

China
Temple Therapeutics BV

Completed

A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions

Pelvic Adhesions

Ukraine
Emory University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Efficacy and Mechanisms of GLN Dipeptide in the SICU (GLND)

Critical Illness

United States
Shahid Beheshti University

Completed

Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients

Critical Illness | Enteral Nutrition | Intestinal Permeability

Iran, Islamic Republic of
Shahid Beheshti University

Completed

Trial of Enteral Glutamine on Clinical Outcomes in Critically Ill Patients

Inflammation | Critical Illness | Enteral Nutrition | Multiple Organ Failure | Infection Complication

Iran, Islamic Republic of
Emmaus Medical, Inc.

Completed

L-glutamine Treatment in Patients With Diverticulosis

Diverticulosis, Colonic

United States
Hawaii Pacific Health

Unknown

The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II

Diabetes Mellitus, Type 2
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat

Pain | Head and Neck Cancer | Cancer-related Problem/Condition

Canada, United States
Emmaus Medical, Inc.
FDA Office of Orphan Products Development

Completed

L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

Sickle Cell Anemia | Thalassemia

United States
Institute of Child Health

Completed

Microbial Invasion During Parenteral Nutrition in Surgical Infants Receiving Glutamine

Surgical Infants Requiring Total Parenteral Nutrition

United Kingdom
Christoph Aufricht

Terminated

Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis

End Stage Renal Disease

Austria
Yonsei University

Unknown

Impact of Perioperative Treatment With Intravenous Glutamine on Myocardial Protection in Cardiac Surgery Patients With Aortic Stenosis

Aortic Valve Stenois

Korea, Republic of
University Hospital, Clermont-Ferrand
Laboratoires NUTRICIA; Société Francophone Nutrition Clinique et Métabolisme; Societe Francaise de Greffe de Moelle et de Therapie Cellulaire

Unknown

Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation. (NEPHA)

Myeloablative Allo-SCT

France
University of Alberta

Completed

Glutamine to Improve Outcomes in Cardiac Surgery (GLADIATOR)

Nosocomial Infection

Canada
Air Force Specialized Hospital, Cairo, Egypt

Recruiting

Effect of IV Alanyl Glutamine on Healing of Pressure Ulcers in Critically Ill Patients

Pressure Ulcer

Egypt
Eastern Regional Medical Center
TSPC America, Inc.

Withdrawn

L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer

Peripheral Neuropathy

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
United States Department of Defense

Active, not recruiting

Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer

Colorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditions

United States
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin

Colorectal Cancer | Metastasis | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal
Ain Shams University

Completed

Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients (Glu_SCD_Egy)

Sickle Cell Disease

Egypt
Medical Center Alkmaar

Unknown

Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients (AIRCo)

Colon Carcinoma

Netherlands
Emmaus Medical, Inc.

Completed

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Sickle Cell Anemia | Sickle ß0-Thalassemia

United States
Tulane University

Completed

Glutamine for the Treatment of Patients With Irritable Bowel Syndrome (AT005291)

Diarrhea-Predominant Irritable Bowel Syndrome

United States
UCSF Benioff Children's Hospital Oakland
Food and Drug Administration (FDA)

Completed

Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension

Sickle Cell Disease | Pulmonary Hypertension | Thalassemia

United States
Emmaus Medical, Inc.

Completed

Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients

Sickle Cell Disease | Pharmacokinetics

United States
Assistance Publique - Hôpitaux de Paris

Completed

Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy (MDB-GLN)

Muscular Dystrophy, Duchenne

France
National Institute of Allergy and Infectious Diseases...

Withdrawn

Glutamine Supplementation in People With Immune Dysregulation

Eczema | MTOROC1 Signaling

United States
Hospital Universitario Dr. Jose E. Gonzalez
Instituto de Información e Investigación en Salud Mental A. C.

Terminated

Treatment of Adults With Generalized Anxiety Disorder Using Glutamine

Generalized Anxiety Disorder

Mexico
Lundquist Institute for Biomedical Innovation at...
Emmaus Medical, Inc.

Terminated

L-Glutamine Therapy for Sickle Cell Anemia

Sickle Cell Anemia | Thalassemia

United States
Rambam Health Care Campus

Unknown

Effects of Dietary Amino Acids on Serum and Macrophage Atherogenicity

Atherosclerosis | Diet Modification | Serum; Disease
Emory University
Emmaus Medical, Inc.

Completed

Glutamine Supplementation in Cystic Fibrosis (CFG)

Cystic Fibrosis | Immune Function

United States
Beth Faiman
National Cancer Institute (NCI)

Terminated

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

Multiple Myeloma | Peripheral Neuropathy | Chemotherapeutic Agent Toxicity

United States
Elijah W. Stommel
Brain Chemistry Labs, Institute for Ethnomedicine

Terminated

Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS) (ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States
M.D. Anderson Cancer Center

Active, not recruiting

Glutamine PET Imaging Colorectal Cancer

Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | RAS Wild Type

United States
University of Virginia
Imperial College London

Recruiting

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) (ACT)

Clostridium Difficile Infection | Clostridium Difficile Diarrhea | Clostridioides Difficile Infection | Clostridia Difficile Colitis

United States
Children's Hospital Medical Center, Cincinnati
University of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaborators

Completed

Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants

Development | Biological Markers | Nutrition | Short Bowel Syndrome | Bloodstream Infections

United States
Andrei Iagaru
National Cancer Institute (NCI)

Completed

18F-FSPG PET/CT for Cancer Patients on Therapy

Stage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Metastatic Renal Cell Cancer | Stage III Renal Cell Cancer | Stage IV Non-Small Cell Lung Cancer | Stage IV Breast Cancer | B-Cell Neoplasm | Stage IIIA Breast Cancer | Stage IV Renal Cell Cancer | Stage IIIC Breast Cancer | Estrogen... and other conditions

United States
All India Institute of Medical Sciences, New Delhi

Completed

Effect of Glutamine on Intestinal Permeability in Crohn's Disease

Crohn's Disease

India
University of Virginia

Terminated

Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection

Clostridium Difficile Infection

United States
University of South Florida
National Cancer Institute (NCI); Children's Oncology Group

Completed

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

Sarcoma | Lymphoma | Kidney Cancer | Leukemia | Neurotoxicity | Peripheral Neuropathy

United States
Instituto Nacional de Cancerologia de Mexico

Recruiting

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Non-Small Cell Lung Cancer With EGFR Mutation

Mexico
Children's Hospital Medical Center, Cincinnati
Universidade Federal do Ceara

Completed

Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy (IMAGINE)

Diarrhea | Malnutrition | Environmental Enteropathy

Brazil
Neuren Pharmaceuticals Limited

Completed

Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC (INTREPID2566)

Brain Injuries

United States
Neuren Pharmaceuticals Limited

Completed

Study of NNZ-2566 in Patients With Traumatic Brain Injury (INTREPID2566)

Brain Injuries

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants (Glutamine)

Sepsis | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States

Search clinical trials for: L-alanyl-L-glutamine dipeptide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations